Research.Patient.info
Type 2 Diabetes and obesity research hub
2 indexed studies · 0 currently recruiting
- ongoing, recruitingHuman Pharmacology (Phase I)- Other
A study investigating the effect of different approved medications on how the body processes the study compound RO7795081. RO7795081 is a new compound that may potentially be used in the treatment of type 2 diabetes and weight control.
This study looks at how your body handles a new medicine called RO7795081. This medicine could help people with type 2 diabetes and those who want to manage their weight. We're testing it with other approved medicines to see what happens.
Netherlands - ongoing, recruitingTherapeutic exploratory (Phase II)
A randomized, double-blind, placebo-controlled proof-of-concept parallel group clinical trial to investigate the efficacy, safety and tolerability of weekly subcutaneous (SC) dosing of CK-0045 in participants with overweight / obesity and Type 2 diabetes
This study is testing a new medicine, CK-0045, for people who have both type 2 diabetes and are overweight. It aims to see if the medicine can help control blood sugar and improve other health markers over 16 weeks.
Germany